COSCIENS Biopharma Inc.
Research COSCIENS Biopharma Inc. (CSCI) on Bullrun: market cap CAD 7.27M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCSCI
- ExchangeTO
- CountryCanada
- SectorHealthcare
- IndustryBiotechnology
- CurrencyCAD
- Market capCAD 7.27M
- Financial periodQ1 2026
- RevenueUSD 1.89M
- Net incomeUSD 10.76M
- Free cash flow-USD 2.18M
- Gross margin42.0%
Valuation Snapshot
latest market cap is CAD 7.27M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 7.50M | -USD 10.36M | -USD 9.18M | 35.3% | n/a | USD 7.31M | USD 2.15M | USD 3.84M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-23 | CAD 7.27M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 CAD.
About COSCIENS Biopharma Inc.
COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a functional ingredient that supports overall health and wellness; oat powder and peptides;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is COSCIENS Biopharma Inc.'s market cap?
COSCIENS Biopharma Inc.'s market capitalization is CAD 7.27M.
What does COSCIENS Biopharma Inc. do?
COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments.